EMPLOYMENT AGREEMENTEmployment Agreement • March 4th, 2003 • Medimmune Inc /De • Biological products, (no disgnostic substances) • Maryland
This EMPLOYMENT AGREEMENT, dated as of August 15, 2002, is by and between Armando Anido (the "Executive") and MEDIMMUNE, INC., a Delaware corporation (the "Company").
AMENDMENT NO. 2Medimmune Inc /De • March 4th, 2003 • Biological products, (no disgnostic substances) • California
This Amendment No. 2, effective on the last date of signature, modifies and amends the Co-Promotion Agreement dated effective November 26, 1997, as amended by the Amendment last executed on July 31, 2000 (together, the "AGREEMENT"), by and between Abbott Laboratories through its Ross Products Division ("ABBOTT"), and MedImmune, Inc. ("MEDIMMUNE").
LICENSE AGREEMENTLicense Agreement • March 4th, 2003 • Medimmune Inc /De • Biological products, (no disgnostic substances) • Iowa
This agreement ("Agreement") is entered into by and between the University of Iowa Research Foundation ("UIRF"), located at 214 Technology Innovation Center, Iowa City, IA 52242 and MedImmune, Inc., ("MedImmune") having a place of business at 35 West Watkins Mill Road, Gaithersburg, Maryland 20878.
2nd AMENDMENT TO THE DISTRIBUTION AGREEMENTDistribution Agreement • March 4th, 2003 • Medimmune Inc /De • Biological products, (no disgnostic substances)
This Second Amendment to the Distribution Agreement ("AGREEMENT"), is entered into as of October 8, 1999 by and between MedImmune, Inc., a Delaware Corporation, having its principal place of business at 35 West Watkins Mill Road, Gaithersburg, MD 20878 ("MEDIMMUNE") and Abbott International, Ltd., a Delaware Corporation, having its principal place of business at 200 Abbott Park Road, Abbot Park, IL 60064.
AMENDMENTMedimmune Inc /De • March 4th, 2003 • Biological products, (no disgnostic substances)
This amendment, effective on the last date of signature modifies and amends the Co-Promotion Agreement dated effective November 26, 1997 (the "AGREEMENT"), by and between Abbott Laboratories through its Ross Products Division, ("ABBOTT") and MedImmune, Inc. ("MEDIMMUNE").
MEDICAL RESEARCH COUNCIL and MEDIMMUNE INC. LICENCE For Winter PatentMedimmune Inc /De • March 4th, 2003 • Biological products, (no disgnostic substances) • Maryland
THIS AGREEMENT is made the thirteenth day of August One thousand nine hundred and ninety seven between MEDICAL RESEARCH COUNCIL of 20 Park Crescent, London WIN 4AL (hereinafter called "MRC" which expression includes its successors and assigns) of the one part and MEDIMMUNE INC. of 35 West Watkins Mill Road, Gaithersburg, Maryland 20878, U.S.A. (hereinafter called "the Licensee" which expression includes its successors and permitted assigns) of the other part.
PUBLIC HEALTH SERVICE BIOLOGICAL MATERIALS LICENSE AGREEMENTLicense Agreement • March 4th, 2003 • Medimmune Inc /De • Biological products, (no disgnostic substances) • District of Columbia
This Agreement is entered into between the Public Health Service ("PHS"), through the Office of Technology Transfer, National Institutes of Health, Box OTT, Bethesda, Maryland 20892, U.S.A. and MedImmune Inc. ("LICENSEE"), a corporation of Delaware, having an office at 35 West Watkins Mill Road, Gaithersburg, Maryland.
AMENDMENT NO. 2Medimmune Inc /De • March 4th, 2003 • Biological products, (no disgnostic substances)
This Amendment No. 2, effective on the last date of signature, modifies and amends the Co-Promotion Agreement dated effective November 26, 1997, as amended by the Amendment last executed on July 31, 2000 (together, the "AGREEMENT"), by and between Abbott Laboratories through its Ross Products Division ("ABBOTT"), and MedImmune, Inc. ("MEDIMMUNE").
AMENDMENT TO THE DISTRIBUTION AGREEMENTDistribution Agreement • March 4th, 2003 • Medimmune Inc /De • Biological products, (no disgnostic substances)
This Amendment to the Distribution Agreement ("AGREEMENT") is entered into as of April 28, 1999 (the "Effective Date") by and between MedImmune, Inc. a Delaware corporation, having its principal place of business at 35 West Watkins Mill Road, Gaithersburg, MD 20878 ("MEDIMMUNE") and Abbott International, Ltd., a Delaware corporation, having its principal place of business at 200 Abbott Park Road, Abbott Park, IL 60064.
SETTLEMENT AGREEMENT AND AMENDMENT TO RSV LICENSE AGREEMENTRSV License Agreement • March 4th, 2003 • Medimmune Inc /De • Biological products, (no disgnostic substances) • Massachusetts
This Settlement Agreement and Amendment to RSV License Agreement (the "Settlement Agreement") is entered into this 16th day of December 2002 (the "Effective Date") by and between MedImmune, Inc. ("MedImmune" or "Licensee"), and the Massachusetts Biologic Laboratories of the University of Massachusetts ("MBL" or "Licensor") (collectively the "Parties");
